Movatterモバイル変換


[0]ホーム

URL:


FR1578974A - - Google Patents

Info

Publication number
FR1578974A
FR1578974AFR1578974DAFR1578974AFR 1578974 AFR1578974 AFR 1578974AFR 1578974D AFR1578974D AFR 1578974DAFR 1578974 AFR1578974 AFR 1578974A
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Application grantedgrantedCritical
Publication of FR1578974ApublicationCriticalpatent/FR1578974A/fr
Expiredlegal-statusCriticalCurrent

Links

Classifications

Landscapes

FR1578974D1968-05-161968-05-16ExpiredFR1578974A (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
FR1520021968-05-16

Publications (1)

Publication NumberPublication Date
FR1578974Atrue FR1578974A (en)1969-08-22

Family

ID=8650309

Family Applications (1)

Application NumberTitlePriority DateFiling Date
FR1578974DExpiredFR1578974A (en)1968-05-161968-05-16

Country Status (3)

CountryLink
FR (1)FR1578974A (en)
GB (1)GB1264677A (en)
IE (1)IE33533B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP0070929A1 (en)*1981-07-251983-02-09Norddeutsche Affinerie AgAgents for the selective control of weeds, and their application

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US8492369B2 (en)2010-04-122013-07-23Clarus Therapeutics IncOral testosterone ester formulations and methods of treating testosterone deficiency comprising same
EP2985026B1 (en)2005-04-152022-08-03Clarus Therapeutics, Inc.Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
US11304960B2 (en)2009-01-082022-04-19Chandrashekar GiliyarSteroidal compositions
US9034858B2 (en)2010-11-302015-05-19Lipocine Inc.High-strength testosterone undecanoate compositions
US9358241B2 (en)2010-11-302016-06-07Lipocine Inc.High-strength testosterone undecanoate compositions
US20180153904A1 (en)2010-11-302018-06-07Lipocine Inc.High-strength testosterone undecanoate compositions
US20120148675A1 (en)2010-12-102012-06-14Basawaraj ChickmathTestosterone undecanoate compositions
WO2016033556A1 (en)2014-08-282016-03-03Lipocine Inc.BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20170246187A1 (en)2014-08-282017-08-31Lipocine Inc.(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20160361322A1 (en)2015-06-152016-12-15Lipocine Inc.Composition and method for oral delivery of androgen prodrugs
CA3078723A1 (en)2016-11-282018-05-31Nachiappan ChidambaramOral testosterone undecanoate therapy
CA3107214A1 (en)2018-07-202020-01-23Lipocine Inc.Liver disease

Cited By (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP0070929A1 (en)*1981-07-251983-02-09Norddeutsche Affinerie AgAgents for the selective control of weeds, and their application

Also Published As

Publication numberPublication date
IE33533B1 (en)1974-08-07
IE33533L (en)1969-11-16
GB1264677A (en)1972-02-23

Similar Documents

PublicationPublication DateTitle
AU1946070A (en)
AU428130B2 (en)
AU2374870A (en)
AU5184069A (en)
AU6168869A (en)
AU6171569A (en)
AU429879B2 (en)
AU4304568A (en)
AU4811568A (en)
AU4744468A (en)
AR203075Q (en)
BE713852A (en)
BE581157A (en)
BE709484A (en)
BE709479A (en)
BE709446A (en)
BE709435A (en)
BE709415A (en)
BE709320A (en)
AU4558658A (en)
BE709301A (en)
BE709274A (en)
BE709138A (en)
BE709119A (en)
BE720156A (en)

Legal Events

DateCodeTitleDescription
STNotification of lapse

[8]ページ先頭

©2009-2025 Movatter.jp